Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
Clinical & Experimental Metastasis
|
April 11, 2025
Ras-proximate-1 (RAP1): a prognosis and therapeutic target in the metastatic spread of breast cancer
Hongyi Liang, Guoliang Yin, Dandan Feng, et al.
Frontiers in Pharmacology
|
December 12, 2022
Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation <i>in vitro</i> and <i>in vivo</i>
Guoliang Yin, Hongyi Liang, Wenxiu Sun, et al.
Chemico-Biological Interactions
|
November 13, 2024
Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation
Guoliang Yin, Hongyi Liang, Yiran Cheng, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
December 4, 2024
[Real-world Study of the Safety and Efficacy of Pembrolizumab in the Treatment of Advanced Non-small Cell Lung Cancer]
Ning Wan, Bing Wang, Ya Guo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
Clinical & Experimental Metastasis
|
April 11, 2025
Ras-proximate-1 (RAP1): a prognosis and therapeutic target in the metastatic spread of breast cancer
Hongyi Liang, Guoliang Yin, Dandan Feng, et al.
Frontiers in Pharmacology
|
December 12, 2022
Shuangyu Tiaozhi decoction alleviates non-alcoholic fatty liver disease by improving lipid deposition, insulin resistance, and inflammation <i>in vitro</i> and <i>in vivo</i>
Guoliang Yin, Hongyi Liang, Wenxiu Sun, et al.
Chemico-Biological Interactions
|
November 13, 2024
Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation
Guoliang Yin, Hongyi Liang, Yiran Cheng, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
December 4, 2024
[Real-world Study of the Safety and Efficacy of Pembrolizumab in the Treatment of Advanced Non-small Cell Lung Cancer]
Ning Wan, Bing Wang, Ya Guo, et al.
Page
of 2